Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Pharmacol Res. 2019 Jul 25;147:104373. doi: 10.1016/j.phrs.2019.104373

Figure 5.

Figure 5.

Structures of MNPs where label-free approaches were used for target identification or validation including didemnin B (DARTS), bryostatin 1 (TS-FITGE) and (3S)-icos-4E-en-1-yn-3-ol (CETSA).